Trials / Sponsors / Takeshi Morimoto

Takeshi Morimoto

Academic / Other · 12 registered clinical trials — 1 currently recruiting.

Status	Trial	Phase	Started
Recruiting	Efficacy and Safety of Aspirin in Patients With Chronic Coronary Syndromes Without Revascularization Stable Angina Pectoris, Coronary Artery Disease, Ischemic Heart Disease	Phase 4	2022-06-14
Completed	Optimal Duration of Anticoagulation Therapy for Low-risk Pulmonary Embolism Patients With Cancer Venous Thrombosis, Neoplasms, Anticoagulants	Phase 4	2021-02-18
Active Not Recruiting	GOREISAN for Heart Failure (GOREISAN-HF) Trial Heart Failure, Edema, Traditional Japanese Medicine	Phase 4	2021-01-19
Completed	Optimal Duration of Anticoagulation Therapy for Isolated Distal Deep Vein Thrombosis in Patients With Cancer S Venous Thrombosis, Neoplasms, Anticoagulant	Phase 4	2019-05-27
Completed	Short and Optimal Duration of Dual Antiplatelet Therapy Study Coronary Artery Disease	Phase 4	2012-09-01
Completed	Intensive Blood Pressure and LDL Lowering in Diabetic Patients With Coronary Artery Disease Type 2 Diabetes, Coronary Artery Disease, Hypertension	Phase 4	2011-08-01
Completed	NOBORI Biolimus-Eluting Versus XIENCE/PROMUS Everolimus-eluting Stent Trial Coronary Artery Disease	Phase 4	2011-05-01
Terminated	Effect of Intensive Blood Pressure Control on Progression of Coronary Atherosclerosis: Randomized Evaluation b Coronary Artery Disease, Hypertension	Phase 4	2010-12-01
Completed	Carvedilol Post-intervention Long-term Administration in Large-scale Trial Myocardial Infarction	Phase 4	2010-07-01
Completed	Evaluation of Routine Follow-up Coronary Angiography After Percutaneous Coronary Intervention Trial Coronary Artery Disease	Phase 4	2010-05-01
Completed	Clopidogrel High Dose Evaluation for the Patient With Coronary Artery Disease in Japan Coronary Artery Disease	Phase 4	2010-02-01
Completed	Randomized Evaluation of Sirolimus-eluting Versus Everolimus-eluting Stent Trial Coronary Artery Disease	Phase 4	2010-02-01